Navigation Links
Urologists Begin Clinical Trials on Treatment of Peyronies Disease

Urologists have recently initiated large scale clinical trials in order to substantiate preliminary results. Pre-Trial Results The previous clinical studies by X4 Labs Inc. were a small scale study which not only looked at the effect of the device on penis curvature but also at its potential as a non-surgical penis enlargement product.

In the clinical trials conducted by the research and development firm, the penis extender was shown to correct Peyronies disease up to 70 percent and results were significantly higher in milder cases. The previous studies also showed significant promise for the penis extender as a non-surgical penile augmentation device.

The controlled sample indicated that males using the penis stretcher for approximately three to six months experienced an increase in penis size of approximately 2.5 inches, with minor variations amongst participants. Urological Trials to Be Conducted The previous clinical trials conducted by X4 Labs Inc. have led to a distinct interest by the urological community, particularly in the use of these devices as an alternative to traditional surgical procedures for the correction of penis curvature.

The penis extender works on the principle of traction, which in essence means that as tension is applied to the penis body it forces cellular division and the creation of new skin tissue. A clinical study will be launched in the upcoming months by the International Andrological Association aimed at substantiating the use of these devices on a wider scale.

As pervasive surgery on the penis can often have drastic side effects such as impotence and loss of sensitivity, the penis extender will be a valuable tool in mild cases of penis curvature. These results will allow for greater use of non-surgical penis extenders within urological clinics. Already medically certified, results of this study may increase urologists prescription of non-surgical devices for the treatment of mild cases of penile curvature.

For Mor Information Please Contact:- Adam Griffin, adam@enlargementworld.com


'"/>




Related medicine news :

1. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
2. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
3. Cancer Begins With Epigenetic Changes: Study
4. Learning About Healthy Diet Choices Begins At Schools
5. China Begins Human Trials For HIV/AIDS Drug
6. Pilot Study to Test Effect of Mobile Phone Transmissions On Skin To Begin In Finland
7. Preparation for Culling Begin at Belghat, Rajangaon and Dhaamnia
8. Make-Up Tips For Beginners
9. Jalgaon: Third Phase Of Culling Operations Begin
10. Human Bird Flu Vaccine Trials Begin In Russia
11. Administration of Fish Drug for Asthma Patients Begins in Andhra
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: